Saturday, July 12th, 2025

Elon Musk’s Support for Weight-Loss Drugs Could Propel Eli Lilly Stock: Analysts See 40% Upside

A Presidential Boost for GLP-1s?

Eli Lilly’s stock, recently hit by postelection volatility, could see a remarkable turnaround, driven in part by high-profile endorsements. Bernstein analysts point to positive signals that suggest the pharmaceutical giant could thrive under the new U.S. administration.

The Backdrop:
The company’s stock slid over 6% following President-elect Donald Trump’s announcement of Robert F. Kennedy Jr., a vaccine skeptic, as his pick for Health and Human Services. But Bernstein analyst Courtney Breen argues the selloff was overdone, especially for Eli Lilly, a leader in GLP-1 weight-loss drugs like Mounjaro and Zepbound.

Two Key Catalysts:

A Strategic Dinner: Eli Lilly CEO David Ricks recently attended a dinner with Trump and Kennedy, alongside other industry leaders. Breen sees this as a signal for potential collaboration on health initiatives.

Elon Musk’s Endorsement: Musk, tasked with a government efficiency initiative by Trump, tweeted his support for making GLP-1 drugs “super low cost,” emphasizing their unparalleled potential to enhance public health.

Why Eli Lilly Stands Out:
Breen highlights the company’s U.S. base and scalability as advantages over competitors like Novo Nordisk. With a 38.2% upside potential and an outperform rating, Eli Lilly is well-positioned for growth.

Despite challenges, Eli Lilly shares are up 35% this year, marking eight consecutive years of gains. Could Musk’s influence and the administration’s focus on health initiatives drive the next surge?

Thank you

APAC Realty Stock Shows Bullish Breakout: Technical Analysis Points to Potential Upside

Comprehensive Stock Analysis: APAC Realty, Hisense Home Appliances, and Weichai Power Comprehensive Stock Analysis: APAC Realty, Hisense Home Appliances, and Weichai Power Broker Name: CGS-CIMB Securities Date of Report: January 9, 2025 APAC Realty...

Nestle (Malaysia): Navigating Challenges Towards a Promising Earnings Recovery

Date: October 27, 2024Broker: Maybank Investment Bank Berhad Company Overview Nestlé (Malaysia) Bhd. is an investment holding company engaged in the manufacture, marketing, and sale of food products. The company operates under the ticker...

“Hong Kong Exchanges & Clearing (HKEX) 2025 Outlook: Strong Growth, ADT Rebound, and Investment Opportunities”

Executive Overview The comprehensive equity research report on Hong Kong Exchanges & Clearing Limited (HKEX) outlines a compelling investment thesis amidst a backdrop of market reforms, capital account liberalisation, and favourable cyclical trends. With...